Apimeds Pharmaceuticals US APUS Ratios (2023-2026)

NYSE APUS
$3.30 -0.20 (-5.65%)
As of: Oct 20, 2026 · 12:58 PM EDT
Reported Financials

Apimeds Pharmaceuticals US Quarterly Ratios

Periods 10 quarters
Latest Jun 2026

Apimeds Pharmaceuticals US ratios data for the quarter ended Jun 2026. These financial ratios cover 10 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 0.14M5.40M9.90M86.72M145.90M
Equity AverageEquity Avg. -0.12M-0.49M-0.88M-1.20M-1.56M3.99M8.95M80.75M129.90M
Invested CapitalInvested Cap. 0.30M-1.11M-1.14M160.44M120.36M
Leverage & Solvency
Interest Coverage RatioInterest Cover -10.10-19.34-9.19-7.65-9.58-115.55-292.69-32.65-1.95
Debt Ratio 0.6319.152.400.040.11
Times Interest Earned -10.10-19.34-9.19-7.65-9.58-115.55-292.69-32.65-1.95
Valuation
Price to BookP/B 1.872.740.130.13
Enterprise Value 9.51M15.40M16.99M13.30M
Market Capitalization 18.25M22.39M20.62M13.58M
Return Ratios
Return on Capital Employed [ROCE]ROCE -78.44%-58.44%-15.67%-14.28%
Return on Assets [ROA]ROA -1,096.06%-68.81%-52.33%-13.94%-14.51%
Return on Equity [ROE]ROE -93.22%-57.88%-14.97%-16.29%

Apimeds Pharmaceuticals US Ratios API

Pull Apimeds Pharmaceuticals US's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=APUS&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY